News
by Anders Bjers | in JPIAMR News | 0 comments
Recently published, in the latest newsletter form EU-JAMRAI, we found an interview with Laura Marin, JPIAMRs Head of Secretariat . The topic is international AMR initiatives and the need of One Health Approach. This fits well with JPIAMRs focus. Our Strategic Research and Innovation Agenda is based on a OneHealth approach, and the initiatives created […]
Read moreby Anna Sundin | in Calls | 0 comments
The Call on Diagnostics and Surveillance 2019 will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call […]
Read moreby Anna Sundin | in News and Events | 0 comments
JPIAMR is participating in the 12th Berlin Conference on Life Sciences “Novel Antimicrobials and AMR Diagnostics 2019”, 14–15 March 2019, Berlin, Germany. Abstract submissions are open now! The conference aims to serve as a platform for SME’s, startups, big pharma, academia, investors and governmental institutions to share ideas, discuss support and strategies to bring new antimicrobials and diagnostics […]
Read moreby Anders Bjers | in JPIAMR News | 0 comments
This is the second global conference on AMR that Wellcome Trust is co-hosting, this time together with the governments of Ghana and Thailand and the United Nations Foundation. The conference takes place in Accra on November 19-20. The Call to Action on AMR 2018, is organised in partnership with the Inter-Agency Coordination Group (IACG) on […]
Read moreby Anna Sundin | in Calls | 0 comments
JPIAMR is pleased to pre-announce a joint transnational research call for proposals for innovative research projects on new or improved diagnostic and surveillance strategies, tools, technologies and methods. The call will support research projects that also have the potential for impact in areas where the risk and burden of AMR is greatest, such as in […]
Read moreby Anna Sundin | in News and Events | 0 comments
Eight networks have been awarded funding within the JPIAMR 2018 call for transnational networks “Building the Foundation of the JPIAMR Virtual Research Institute.” Each funded network will receive €50,000 to establish expertise clusters to identify research community needs and develop ideas to form the foundation for the JPIAMR Virtual Research Institute (JPIAMR-VRI). The call was […]
Read moreby Anna Sundin | in News and Events | 0 comments
Ten networks have been awarded funding within the JPIAMR 7th transnational call: “2018 Network Call on Surveillance”. Each funded network will receive €50,000 to enhance resource alignment and efforts in the field of AMR surveillance. The call was launched in May 2018 and supported by ten research-funding organisations from JPIAMR member countries. Sixteen applications were received, […]
Read moreby Anna Sundin | in News and Events | 0 comments
Ten projects have been awarded funding within the JPIAMR 6th transnational call: “Innovations against antibiotic-resistant bacteria: New targets, compounds and tools”. The total funding amount is 12,8 M€. The call was launched in January 2018 and supported by 16 research-funding organisations from JPIAMR member countries. The primary aim of the call is to combine the […]
Read moreby Anders Bjers | in JPIAMR News | 0 comments
The JPIAMR Working Group on Antimicrobial Resistance and Rapid Diagnostic Testing has published a Consensus Statement – Developmental Roadmap for antimicrobial susceptibility testing systems, in Nature, (October 17, 2018). We are pleased to see Nature publishing a review and the statement of the working group organised by JPIAMR. The group has made a thorough analysis on […]
Read moreby Anna Sundin | in News and Events | 0 comments
Pew Trust has launched a publicly available interactive tool to provide data to help scientists around the world to identify urgently needed new antibiotics. The pipeline of products in development to treat or prevent bacterial infections is stagnant and cannot meet today’s urgent and growing patient needs. Experts have repeatedly identified information sharing as essential to spurring […]
Read more